MRFR@Press Releases

The Clinical Decision Support Systems Market was valued at USD 1600 million in 2017 and is expected to register a CAGR of 11.5% during the forecast period, 2018–2023. The global clinical decision support systems market is majorly driven by government support and initiatives, growing occurrence of medication errors, rising prominence and usage of big data and mHealth tools, high returns on investments for CDSS solutions, and growing adoption of cloud computing in healthcare. However, factors such as high investments and lack of interoperability are likely to hamper the growth of the market. Clinical Decision Support Systems Market Key Players: Cerner, Epic Systems, Mckesson, Meditech, Philips Healthcare, Wolters Kluwer Health, Hearst Health, Elsevier B.V., IBM, and Allscripts Healthcare Solutions, among others. Segmentation:                                                                                                                The Global Clinical Decision Support System

This study covers the market dynamics and trends in major countries that are expected to influence the current market scenario and future status of the Global Medical Device Connectivity Market over the forecast period. Market Overview: The Global Medical Device Connectivity market is expected to grow at an approximate CAGR of 16.1% during the forecast period, 2018–2023. Moreover, the increasing penetration of Electronic Health Records (EHRs) and health information exchange systems in healthcare organizations, are the factors responsible for the market growth. Major factors responsible for the market growth are penetration of EHRs through the collaboration between IT service providers and healthcare service providers. For instance, in 2016, Allscripts Technologies signed a ten years strategic agreement with Optumcare to deploy Allscripts TouchWork suite as its exclusive Electronic Health Record (EHR) and Practice Management (PM) solution for physicians. The strategic agreement wi

Namely Orphan Drugs Market Report has Been Published by Market Research Future Which Covers All the Geographical Locations with Demand, Trend Analysis with near about Forecasted results and Also Covers the Market Expectations. Global orphan drugs (Global orphan drugs) are drugs used for the treatment of rare diseases and disorders that affects a small percentage of the population. There are approximately 7,000 different types of rare diseases and disorders and an estimated 30 million people in the United States, 30 million in Europe and 350 million people worldwide suffer from rare disease. Four fifth of rare diseases are genetic in origin, with 50% of the people affected being children. The distribution of rare diseases is skewed with four fifth cases accounted by some 350 rare diseases. Only 5% of rare diseases have approved drug treatment with only 326 new drugs being approved by the FDA and brought to market. In 2015, orphan drug sales were of the order of 93 billion. Orpha

The Analysis presents the study of Worldwide Hepatitis C Drugs facilitating the regional and country wise analysis covering the strategic analysis of each market player and the market share they hold Hepatitis is inflammation of the liver characterized by yellowed eyes and skin due to bilirubin, flu-like symptoms which include nausea, vomiting, poor appetite, joint pain, headaches, clay colored stools etc. Hepatitis is caused by a variety of factors both microbial and non-microbial. However hepatitis C is caused by hepatitis C virus and affects between 130–150 million people globally every year of which approximately 700 000 people die from hepatitis C-related liver diseases. What is of greater concern is the fact that 15 to 20% of chronically infected patients develop liver cirrhosis or liver cancer Get 100 Pages Hepatitis C Drugs Market Sample Copy Which covers 4 Regions and 8+ Companies Strategy with Respect to Tables and Figures in Supported is Now Available at  https://www

This study covers the market dynamics and trends in major countries that are expected to influence the current market scenario and future status of the Global Bone Biopsy Market over the forecast period. Bone biopsy is a procedure in which a sample of bone tissue is taken and observed under the microscope to diagnose various bone disorders such as osteopenia. It is of two types namely, needle biopsy and open biopsy. In needle biopsy, a biopsy needle is used to take the tissue sample. In open biopsy, an incision is made through the skin and the sample is taken. Bone cancer, bone infection or inflammation, chronic kidney disease and osteoporosis are major indications for bone biopsy. The Global  Bone Biopsy Market  is expected to grow at a CAGR of 5.7% during the forecast period. Rising prevalence of cancer and increasing demand for new diagnostic procedures are the major factors driving the growth of the market across the globe. Furthermore, increasing healthcare expenditure and

This study covers the market dynamics and trends in major countries that are expected to influence the current market scenario and future status of the Global Lactate Dehydrogenase Test Market over the forecast period. Lactate dehydrogenase (LDH) is an enzyme occurring in most body tissues such as the liver, heart, pancreas, kidneys, muscles, blood cells etc. that is required for converting sugar into energy. The values of LDH are directly proportional to the disease condition of the body and during diseases the values of LDH increases denoting variety of conditions such as stroke, liver diseases, muscle dystrophy, fatigue etc. Lactate Dehydrogenase Test Market  is expected to reach $ 6.4 billion by the end of 2023, this market is projected to growing at a CAGR of ~ 8.8 % during 2017-2023. The market for lactate dehydrogenase test is rising due to increasing occurrence of diseases such as cerebrovascular diseases, liver diseases, blood disorders, muscle dystrophy etc. Further f

Namely Polyps Market Report has Been Published by Market Research Future Which Covers All the Geographical Locations with Demand, Trend Analysis with near about Forecasted results and Also Covers the Market Expectations. A polyp is an abnormal growth of tissue projecting from a mucous membrane commonly found in the colon, stomach, nose, ear, sinus, urinary bladder, uterus etc. although they may occur elsewhere in the body where mucous membranes exist. Most polyps are benign or non-cancerous while a few are premalignant. Premalignant polyps can be a trigger factors for cancer and in general, the larger the polyp, the greater the risk of cancer, especially with pre-malignant polyps. Most polyps have no symptoms and screening is the only reliable measure to detect them. Symptoms, when evident, are irregular periods and vaginal bleeding in women, dysmenorrhea, pain, diarrhoea, constipation, nausea, vomiting etc. depending on the location of the polyp. Get Premium Sample Copy of Polyp

The Market Research Future has been published New Research Reports which is  Buerger’s Disease Market  & In This Report the Information has been Provided like Market Analysis, Scope, Stake, Progress, Trends & Forecast which is making through primary and secondary research which is done by professional healthcare researcher. Buerger’s disease is also known as thromboangiitis obliterans (TAO). Buerger’s disease is a rare and severe disease of veins and arteries especially in arms and legs. In this disease, blockage of blood vessels of hands and feet occurs in this disease condition. Blood clots or thrombi obstruct the blood vessels, resultantly, the blood vessels become inflamed and swell which reduces the blood flow. This leads to the destruction or damage of skin tissues that may cause gangrene and other infections. The exact causes of this disease are unknown but tobacco is believed to be responsible to an extent, in the development of this disease. Some major symptoms of